Breadcrumbs Home Media Press Releases Press Releases Press Releases Regulatory Press Releases More Press Releases Data Year20262025202420232022202120202019201820172016201520142013201220112010 2019-12-12 08:00Moberg Pharma comments on the results of the North American Phase 3 study with MOB-015Read more 2019-12-09 08:00Moberg Pharma meets primary endpoint for MOB-015 in a Phase 3 study for the treatment of onychomycosisRead more 2019-11-29 08:30Reclassification of series B shares in Moberg Pharma AB (publ)Read more 2019-11-19 08:00Moberg Pharma AB Interim report July - September 2019Read more 2019-11-12 08:00Moberg Pharma's Interim report for July - September 2019 to be published on November 19 - Invitation to teleconferenceRead more 2019-10-30 18:30Bulletin from Moberg Pharma's AGM on October 30th , 2019Read more Pagination First page Previous page … Page 25 Page 26 Page 27 Page 28 Current page 29 Page 30 Page 31 Page 32 Page 33 … Next page Last page Press Releases Data Year20262025202420232022202120202019201820172016201520142013201220112010 2018-10-30 08:00Moberg Pharma's report for the third quarter to be published on November 6 - Invitation to teleconferenceRead more 2018-09-18 08:30Moberg Pharma and Cipher Pharmaceuticals sign exclusive license agreement for MOB-015 in CanadaRead more 2018-09-11 08:30Moberg Pharma has completed enrollment to Phase 3 study for MOB-015 in North AmericaRead more 2018-08-13 10:30Appointment of Chief Medical Officer at Moberg PharmaRead more 2018-08-07 08:00Moberg Pharma AB interim report January - June 2018Read more 2018-07-30 08:00Moberg Pharma's report for the second quarter to be published on August 7 - Invitation to teleconferenceRead more Pagination First page Previous page … Page 25 Page 26 Page 27 Page 28 Current page 29 Page 30 Page 31 Page 32 Page 33 … Next page Last page
